This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Lamb Weston (LW) Stock Up More Than 15% in 3 Months: Here's Why
by Zacks Equity Research
Lamb Weston (LW) is benefiting from effective pricing actions. The company's efforts to boost production capacity and fuel long-term growth are noteworthy.
Helen of Troy (HELE) Looks Troubled: Stock Down 25% in 3 Months
by Zacks Equity Research
Helen of Troy (HELE) has been battling escalated cost concerns and softness in its Beauty segment. Management lowered its fiscal 2023 guidance on the last earnings call.
The Estee Lauder Companies (EL) Rides on Robust Skin Care Unit
by Zacks Equity Research
The Estee Lauder Companies (EL) boasts a solid Skin Care portfolio, which has been aiding growth. The company is benefiting from a strong online business.
TreeHouse Foods (THS) Looks Promising: Pricing a Major Driver
by Zacks Equity Research
TreeHouse Foods (THS) has been gaining from the favorable demand for private label products and efficient pricing initiatives.
The J.M. Smucker (SJM) Gains on Solid Pricing, Coffee Business
by Zacks Equity Research
The J.M. Smucker (SJM) has been benefiting from strength in the coffee business, a focus on core strategies, a revival in the Away from Home division and pricing amid cost inflation and supply-chain woes.
Nu Skin's (NUS) Focus on Nu Vision 2025 & Product Launches Aids
by Zacks Equity Research
Nu Skin (NUS) is optimistic about its Nu Vision 2025 strategy to become the world's leading integrated beauty and wellness company, driven by a dynamic affiliate opportunity platform.
McCormick (MKC) Q3 Earnings Beat Estimates, Sales Increase Y/Y
by Zacks Equity Research
McCormick's (MKC) third-quarter fiscal 2022 results reflect higher sales on strength in both segments. However, earnings decline year over year.
Conagra (CAG) Q1 Earnings Top Estimates, Sales Increase Y/Y
by Zacks Equity Research
Conagra Brands' (CAG) first-quarter fiscal 2023 results reflect increased earnings and sales. In spite of favorable pricing, volume declines persist.
Helen of Troy (HELE) Cuts FY23 View Despite Q2 Earnings Beat
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2023 results reflect lower earnings. Management lowers sales and earnings guidance for fiscal 2023.
Lamb Weston (LW) Q1 Earnings Top Estimates, Sales Rise Y/Y
by Zacks Equity Research
Lamb Weston's (LW) first-quarter fiscal 2023 results reflect increased earnings and sales due to the robust pricing undertaken to battle the significant cost inflation.
Is Hershey (HSY) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Hershey (HSY) and Smucker (SJM) have performed compared to their sector so far this year.
Beat the Market Like Zacks: ADP, Walmart, Starbucks in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Post Holdings (POST) Benefits From Buyouts, Foodservice Unit
by Zacks Equity Research
Post Holdings (POST) has been gaining from acquisitions and a recovery in the Foodservice business. These, along with pricing, bode well for the company amid cost inflation.
Pilgrim's Pride (PPC) is Poised on Capacity Expansion Efforts
by Zacks Equity Research
Pilgrim's Pride (PPC) benefits from its focus on strategic growth initiatives, like capacity expansions and a customer-centric approach.
United Natural (UNFI) Q4 Earnings Top Estimates, Sales Rise
by Zacks Equity Research
United Natural's (UNFI) fourth-quarter fiscal 2022 results reflect higher earnings and sales, with all channels witnessing sales growth. Management issues an encouraging view for fiscal 2023.
The Estee Lauder Companies (EL) & BALMAIN to Launch a Beauty Line
by Zacks Equity Research
The Estee Lauder Companies (EL) signs a license agreement with BALMAIN to introduce BALMAIN BEAUTY. The collaboration is likely to launch in fall 2024.
Kimberly-Clark's (KMB) Growth Pillars & Cost Cutting Efforts Aid
by Zacks Equity Research
Kimberly-Clark (KMB) is focused on its three key strategic growth pillars. The company is undertaking relevant cost-cutting initiatives amid the inflationary environment.
Take the Zacks Approach to Beat the Market: Uber, Starbucks, Livent, Carter Bankshares in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
COTY Pulls Up Q1 View on Solid Demand for Beauty & Skin Care
by Zacks Equity Research
COTY is seeing solid beauty demand in the near term, pushing management to raise its first-quarter fiscal 2023 view. It expects to double skincare revenues by fiscal 2025.
Service Corporation (SCI) Hurt by Costs, Down 10% in 6 Months
by Zacks Equity Research
Service Corporation's (SCI) corporate general and administrative costs have been rising year over year. The company's bottom line declined in the second quarter of 2022.
General Mills (GIS) Tops Q1 Earnings Estimates, Raises View
by Zacks Equity Research
General Mills' (GIS) first-quarter fiscal 2023 results reflect increased earnings and sales. Management raises its fiscal 2023 guidance.
Lamb Weston (LW) Up More Than 15% in 3 Months: Here's Why
by Zacks Equity Research
Lamb Weston (LW) benefits from capacity expansion efforts and a robust price/mix amid escalated input cost concerns.
Mondelez (MDLZ) Faces Cost Woes, Banks on Efficient Pricing
by Zacks Equity Research
Mondelez (MDLZ) has been battling cost inflation for a while. Efficient pricing efforts and contributions from buyouts have been upsides.
Altria (MO) Benefits From Pricing Power, Hurt by Low Volumes
by Zacks Equity Research
Altria Group's (MO) strong pricing power has been aiding it amid soft volumes and high costs. Focus on reduced-risk products also bodes well.
Philip Morris (PM) Hikes Dividend: Things You Should Know
by Zacks Equity Research
Philip Morris (PM) announces a dividend hike of 1.6%, taking its quarterly rate to $1.27 per share. The company has been gaining from its pricing power and strength in reduced risk products.